Select region

Press release Göteborg 2015-02-18


The shareholders of Getinge AB (publ) are hereby invited to attend the Annual General Meeting (“AGM”) to be held on Wednesday 25 March 2015 at 2.00 p.m. CET, in Kongresshallen, Hotel Tylösand, Halmstad, Sweden.


Shareholders who wish to attend the AGM must:

      be recorded in the share register kept by Euroclear Sweden AB (the Swedish central securities depository), on Thursday 19 March 2015, and

      notify the company of their intention to attend the AGM by Thursday 19 March 2015, preferably before 4.00 p.m. CET.

In order to participate in the AGM, shareholders with nominee-registered shares should request their bank or broker to have the shares temporarily owner-registered with Euroclear Sweden AB by Thursday 19 March 2015. Shareholders therefore are requested to notify their nominees in due time before the said date.


Notice of attendance shall be made in writing to Getinge AB, “AGM”, P.O. Box 7841, SE-103 98 Stockholm, Sweden, or by telephone +46 10 335 08 18, or on the company’s website, The notice of attendance shall state name, personal (or corporate) identity number, shareholding, telephone number and name of advisor, if any. An entrance card to be shown when registering for the AGM will be sent in confirmation of the notice of attendance. Shareholders represented by proxy should submit a power of attorney to the company before the AGM. A proxy form pursuant to the provisions in Chapter 7, section 54 a of the Swedish Companies Act is available at the company and on the company’s website, Representatives of a legal entity shall present a copy of the certificate of registration or similar document of authorisation.


  1. Opening of the Meeting
  2. Election of Chairman of the Meeting
  3. Preparation and approval of the voting list
  4. Approval of the agenda
  5. Election of two persons to approve the minutes
  6. Determination of compliance with the rules of convocation
  7. Presentation of

(a)      the Annual Report and the Auditor’s Report

(b)      the Consolidated Accounts and the Group Auditor’s Report

(c)      the statement by the auditor on the compliance of the Guidelines for Remuneration to Senior Executives applicable since the last AGM

(d)      the Board’s proposal for distribution of the company’s profit and the Board’s reasoned statement thereon

  1. Report on the work of the Board of Directors, including the work and functions of the Remuneration Committee and the Audit Committee
  2. The CEO’s report
  3. Resolution regarding adoption of the Income Statement and the Balance Sheet as well as the Consolidated Income Statement and the Consolidated Balance Sheet
  4. Resolution regarding dispositions in respect of the Company’s profit according to the adopted Balance Sheet and determination of record date for dividend
  5. Resolution regarding discharge from liability for the Board of Directors and the CEO
  6. Establishment of the number of Board members
  7. Establishment of fees to the Board of Directors (including fees for work in Committees)
  8. Election of the Board of Directors     
  9. Resolution regarding Guidelines for Remuneration to Senior Executives
  10. Closing of the Meeting


At the AGM in 2005, principles for the establishment of a Nomination Committee were adopted, entailing that the Nomination Committee shall consist of the Chairman of the Board, representatives of each of the company’s five largest shareholders per 31 August each year and one representative of the minor shareholders. The Nomination Committee in respect of the 2015 AGM consists of Carl Bennet (Carl Bennet AB), Marianne Nilsson (Swedbank Robur AB), Per Colleen (Fjärde AP-fonden), John Hernander (Nordea Fonder), Adam Nyström (Didner & Gerge Fonder) and Viveka Ekberg as the representative of the minor shareholders.

The Nomination Committee has proposed the following:

Chairman of the AGM: The Chairman of the Board, Carl Bennet, shall be elected Chairman of the AGM.

Board of Directors: The number of Board members elected by the General Meeting shall remain unchanged at eight members, with no deputy members. As Board members, re-election shall be made of Carl Bennet, Johan Bygge, Cecilia Daun Wennborg, Carola Lemne, Malin Persson, Johan Stern and Maths Wahlström. Alex Myers shall be elected new member of the Board. As Chairman of the Board, Carl Bennet shall be re-elected. Johan Malmquist has declined re-election.

Alex Myers (born 1963; Bachelor of Arts, Organizational Behavior, Yale University) takes over as CEO and President of Getinge in connection with the Annual General Meeting. Alex Myers comes from the position as CEO and President of Hilding Anders, but he has previously worked in Getinge Group as CEO of ArjoHuntleigh and Business Area Manager of Extended Care from 2009 - 2013. Before then he was a member of the group management of Carlsberg for ten years, the last five as manager of the Western European markets. Alex Myers is also a board member of Duni AB.

Board and Committee fees: Board fees, excluding remuneration for Committee work, shall amount to a total of SEK 4,400,000 of which SEK 1,100,000 to the Chairman and SEK 550,000 to each of the other Board members elected by the General Meeting who are not employees of the Getinge group. Work in the Audit Committee shall be compensated with SEK 240,000 to the Chairman and SEK 120,000 to each of the other members. Work in the Remuneration Committee shall be compensated with SEK 125,000 to the Chairman and SEK 92,000 to each of the other members.

DIVIDEND (item 11)

The Board and the CEO have proposed that a dividend of SEK 2.80 per share be declared. As record date for the dividend the Board proposes Friday 27 March 2015. If the AGM resolves in accordance with the proposal, the dividend is expected to be distributed by Euroclear
Sweden AB starting Wednesday 1 April 2015.

tHe board’s proposal regarding guidelines for remuneration to senior executives (item 16)

The Board proposes that the AGM resolves upon guidelines for remuneration to senior executives principally entailing the following. Remuneration and other terms and conditions of employment for senior executives shall be based on market conditions and be competitive in all markets where Getinge operates, to ensure that competent and skilful employees can be attracted, motivated and retained. The total remuneration to senior executives shall comprise basic salary, variable remuneration, pensions and other benefits. The variable remuneration shall be limited and connected to predetermined and measurable criteria elaborated with the purpose to promote the long-term added value of the company. In addition to the variable remuneration, approved share or share-related incentive programs may occasionally be implemented. The Board shall retain the right to deviate from the guidelines if motivated by particular reasons on an individual basis.


Financial statements, Auditor’s Report and other documents pursuant to item 7, the Board’s reasoned statement under item 11 and the complete proposal for the resolution under item 16 will be available at the company and on the company’s website,, as from Wednesday 4 March 2015 at the latest and will be sent to shareholders upon request. Copies will also be available at the AGM.

The Board and the CEO shall at the AGM, if any shareholder so requests and the Board believes that it can be done without significant harm to the company, provide information regarding circumstances that may affect the assessment of an item on the agenda, circumstances that can affect the assessment of the company’s or its subsidiaries’ financial position and the company’s relation to other companies within the group.

The total number of shares in the company amounts to 238,323,377, whereof 15,940,050 shares of series A and 222,383,327 shares of series B. The total number of votes in the company amounts to 381,783,827.


Gothenburg in February 2015

The Board of Directors of Getinge AB (publ)

Getinge Group is a leading global provider of products and systems that contribute to quality enhancement and cost efficiency within healthcare and life sciences. We operate under the three brands of ArjoHuntleigh, Getinge and Maquet. ArjoHuntleigh focuses on patient mobility and wound management solutions. Getinge provides solutions for infection control within healthcare and contamination prevention within life sciences. Maquet specializes in solutions, therapies and products for surgical interventions, interventional cardiology and intensive care.

The information is such that Getinge AB must disclose in accordance with the Swedish Securities Market Act and/or the Financial Instruments Trading Act.